Coeptis Therapeutics, Inc. Cash
Coeptis Therapeutics, Inc. had Cash of $7.37 million as of 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:Cash · last filed 2022-11-08
- 2022-09-30: Cash $7.37M.
- 2022-06-30: Cash $2.38M.
- 2022-03-31: Cash $2.34M.
- 2021-12-31: Cash $2.18M.
| Period end | Cash |
|---|---|
| 2022-09-30 | $7.37M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $2.38M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $2.34M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $2.18M 10-Q · filed 2022-11-08 |
| 2021-09-30 | $2.81M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $1.91M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $2.03M 10-Q/A · filed 2021-05-18 |
| 2020-12-31 | $202.97K 10-K · filed 2022-03-11 |
| 2020-09-30 | $470.08K 10-Q · filed 2021-11-15 |
| 2020-06-30 | $379.81K 10-Q · filed 2021-08-16 |
| 2020-03-31 | $349.46K 10-Q/A · filed 2021-05-18 |
| 2019-12-31 | $440.09K 10-Q · filed 2021-11-15 |